Schrickel, Jan W <br/><br/>
Rationale and design of the ODIn-AF Trial: randomized evaluation of the prevention of silent cerebral thromboembolism by oral anticoagulation with dabigatran after pulmonary vein isolation for atrial fibrillation.  [electronic resource] 

 -  Clinical research in cardiology : official journal of the German Cardiac Society  Feb 2016 
 - 95-105 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1861-0692 
<br/><br/><label>Standard No.: </label>10.1007/s00392-015-0933-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Anticoagulants--administration & dosage<br/>Atrial Fibrillation--complications<br/>Catheter Ablation--methods<br/>Dabigatran--administration & dosage<br/>Hemorrhage--chemically induced<br/>Humans<br/>Intracranial Embolism--etiology<br/>Prospective Studies<br/>Pulmonary Veins--surgery<br/>Research Design